Lineweaver Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lineweaver Wealth Advisors's PFE Position: Q1 2024 in Review
Lineweaver Wealth Advisors sold out of Pfizer (PFE) in Q1 2024, closing a stake of 13,130 shares — an estimated $378K sold.
Lineweaver Wealth Advisors first reported a position in PFE in Q4 2019 and held it in 17 quarters. The position peaked at $2.79M in Q4 2022. 2,882 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Lineweaver Wealth Advisors reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Lineweaver Wealth Advisors sold 13,130 Pfizer shares in Q1 2024, an estimated $378K.
- Lineweaver Wealth Advisors first reported a position in Pfizer in Q4 2019 and held it in 17 quarters.
- Lineweaver Wealth Advisors's Pfizer position peaked at $2.79M in Q4 2022.
- 2,882 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Lineweaver Wealth Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.